FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.3884
-0.0325 (-7.72%)
At close: Oct 29, 2025, 4:00 PM EDT
0.3979
+0.0095 (2.45%)
After-hours: Oct 29, 2025, 5:05 PM EDT
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $16.27 million as of October 29, 2025. Its market cap has decreased by -82.25% in one year.
Market Cap
16.27M
Enterprise Value
19.56M
1-Year Change
-82.25%
Ranking
Category
Stock Price
$0.39
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $16.27M, a decrease of -98.28%. That is a compound annual growth rate of -90.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 17.63M | -74.87% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.90B |
| Johnson & Johnson | 457.53B |
| AbbVie | 402.83B |
| UnitedHealth Group | 331.46B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.35B |